Recurrences Completed Phase 2 Trials for Naltrexone (DB00704)

Back to Recurrences

Also known as: Recurrence

IndicationStatusPhase
DBCOND0050633 (Recurrences)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01874951Low-Dose Naltrexone (LDN) for Depression Relapse and RecurrenceTreatment